Ujvira
Ujvira Products are primarily used for
Multiple sclerosis (MS), Metastatic breast cancer, Psoriasis
About Ujvira Products
Uses of Ujvira Products
Trastuzumab Emtansine is used in the treatment of multiple sclerosis (MS), metastatic breast cancer and psoriasis.
Ujvira Products side effects
Common
Side Effects of Ujvira are Nausea, Diarrhea, Headache, Vomiting, Constipation, Dryness in mouth, Abdominal pain, Fatigue, Fever, Weakness, Urinary tract infection, Low blood platelets, Anemia (low number of red blood cells), Insomnia (difficulty in sleeping), Peripheral neuropathy (tingling and numbness of feet and hand), Hemorrhage, Nosebleeds, Cough, Breathlessness, Stomatitis (Inflammation of the mouth), Increased transaminase level in blood, Musculoskeletal (bone, muscle or joint) pain, Joint pain, Muscle pain.
How Ujvira Products work
Trastuzumab Emtansine seeks out and latches onto cancer cells with a protein called HER2. HER2-positive cancer cells have a lot of this protein, which helps them grow quickly. Once Trastuzumab Emtansine attaches to a HER2-positive cell, it goes inside the cell and helps kill the cancer cell from the inside without affecting as many healthy cells around it.
Patient Concerns about Ujvira Products
Frequently asked questions about Ujvira Products
Frequently asked questions about Trastuzumab Emtansine
Q. What is Trastuzumab Emtansine used for?
Trastuzumab Emtansine is used to treat HER2-positive metastatic breast cancer by focusing specifically on HER2-positive cancer cells to slow down or stop their growth. It delivers the chemotherapy directly inside the cell, which helps limit damage to healthy cells and increases the effectiveness of the treatment.
Q. How is Trastuzumab Emtansine administered?
Trastuzumab Emtansine is given as an intravenous (IV) infusion in a hospital or clinic setting, usually once every three weeks. Depending on your treatment plan, each session may last 30–90 minutes.
Q. Can I take Trastuzumab Emtansine if I am pregnant or breastfeeding?
No, Trastuzumab Emtansine is not recommended during pregnancy or breastfeeding, as it may harm the unborn baby or pass into breast milk. Women of childbearing age should use effective contraception during treatment and for several months after.
Q. Will I need regular monitoring while on Trastuzumab Emtansine?
Regular monitoring is essential, as Trastuzumab Emtansine can affect liver function and the heart. Your doctor will schedule periodic blood tests and possibly heart function tests to ensure safe treatment.
Q. What should I avoid while receiving Trastuzumab Emtansine?
Avoid alcohol, as it can increase liver strain, and always inform your doctor of any other medications or supplements you are taking, as certain drugs may interact with Trastuzumab Emtansine.
Q. How long will I need to take Trastuzumab Emtansine?
The duration of treatment varies depending on individual response and your doctor’s recommendation. Your doctor will assess your progress to determine how long you should continue with Trastuzumab Emtansine.
Q. Can I miss a dose or reschedule an infusion session?
To maintain consistent treatment levels, it is best to keep all scheduled appointments. If you need to reschedule, contact your doctor to find the next available date.
Q. What should I do if I experience unusual symptoms during treatment?
If you notice severe fatigue, chest pain, shortness of breath, or symptoms of liver issues like yellowing of the skin or eyes, contact your doctor immediately. These may require urgent attention.
Products for Ujvira
No products found
Substitute brands for Ujvira
2 Products